Xuede Lin

773 total citations
9 papers, 84 citations indexed

About

Xuede Lin is a scholar working on Oncology, Immunology and Pathology and Forensic Medicine. According to data from OpenAlex, Xuede Lin has authored 9 papers receiving a total of 84 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 4 papers in Immunology and 2 papers in Pathology and Forensic Medicine. Recurrent topics in Xuede Lin's work include Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (4 papers) and Chemokine receptors and signaling (2 papers). Xuede Lin is often cited by papers focused on Immunotherapy and Immune Responses (4 papers), Immune Cell Function and Interaction (4 papers) and Chemokine receptors and signaling (2 papers). Xuede Lin collaborates with scholars based in United States, China and Slovakia. Xuede Lin's co-authors include Joyce C. Solheim, Abdelkader E. Ashour, James E. Talmadge, Hēth Turnquist, Rakesh K. Singh, Michael A. Hollingsworth, Xiaohui Chen, Sheng Zhang, Kunshou Zhu and Mingang Ying and has published in prestigious journals such as Digestive Diseases and Sciences, Cancer Immunology Immunotherapy and Cancer Biology & Therapy.

In The Last Decade

Xuede Lin

9 papers receiving 83 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Xuede Lin United States	5	54	44	20	12	10	9	84
David Halverson United States	4	44 0.8×	42 1.0×	16 0.8×	29 2.4×	8 0.8×	9	89
Simone Ostrouska Australia	3	75 1.4×	88 2.0×	48 2.4×	8 0.7×	9 0.9×	5	139
Anne Calvez France	2	92 1.7×	85 1.9×	29 1.4×	13 1.1×	13 1.3×	2	139
R. Scott Mead Australia	5	48 0.9×	13 0.3×	28 1.4×	29 2.4×	16 1.6×	5	91
Benoit Fiset Canada	6	38 0.7×	39 0.9×	29 1.4×	10 0.8×	9 0.9×	10	91
Diala Abd-Rabbo Canada	6	30 0.6×	34 0.8×	54 2.7×	11 0.9×	9 0.9×	9	107
Lucile Vanhersecke France	5	105 1.9×	63 1.4×	18 0.9×	10 0.8×	38 3.8×	17	133
Yasmin Nouri New Zealand	5	26 0.5×	34 0.8×	36 1.8×	9 0.8×	10 1.0×	6	79
Miguel Caballero‐Baños Spain	5	60 1.1×	72 1.6×	23 1.1×	5 0.4×	4 0.4×	9	100
Anne Song United States	4	30 0.6×	49 1.1×	60 3.0×	18 1.5×	8 0.8×	4	130

Countries citing papers authored by Xuede Lin

Since Specialization

Citations

This map shows the geographic impact of Xuede Lin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xuede Lin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xuede Lin more than expected).

Fields of papers citing papers by Xuede Lin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xuede Lin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xuede Lin. The network helps show where Xuede Lin may publish in the future.

Co-authorship network of co-authors of Xuede Lin

This figure shows the co-authorship network connecting the top 25 collaborators of Xuede Lin. A scholar is included among the top collaborators of Xuede Lin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xuede Lin. Xuede Lin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

9 of 9 papers shown

Deng, Yujie, Xiaohui Chen, Kunshou Zhu, et al.. (2016). Histological characterisation and prognostic evaluation of 62 gastric neuroendocrine carcinomas. Współczesna Onkologia. 4(4). 311–319. 10 indexed citations

Lin, Xuede, et al.. (2014). Salvage therapy with mitoxantrone, etoposide, bleomycin and dexamethasone for refractory or relapsed aggressive non-Hodgkin’s lymphoma patients with a poor performance status or comorbidity. Oncology Letters. 8(5). 2012–2016. 2 indexed citations

Huang, Liming, Xi Shi, Min Zheng, et al.. (2014). Association Between ERCC2 Polymorphisms and Glioma Risk: a Meta-analysis. Asian Pacific Journal of Cancer Prevention. 15(11). 4417–4422. 9 indexed citations

Zhang, Zhifeng, Xi Shi, Xiaoyan Lin, et al.. (2010). [Inhibitory effect of photodynamic therapy combined with paclitaxel on the proliferation of esophageal carcinoma Eca-109 cells].. PubMed. 30(6). 1310–2, 1315. 1 indexed citations

Lin, Xuede, et al.. (2008). Effect of invariant chain on major histocompatibility complex class I molecule expression and stability on human breast tumor cell lines. Cancer Immunology Immunotherapy. 58(5). 729–736. 3 indexed citations

Ashour, Abdelkader E., Hēth Turnquist, Nicole Burns, et al.. (2007). Flt3 Ligand Delivered in a Pluronic Formulation Prolongs the Survival of Mice with Orthotopic Pancreatic Adenocarcinoma. Cancer Biotherapy and Radiopharmaceuticals. 22(2). 235–238. 4 indexed citations

Ashour, Abdelkader E., Xuede Lin, Xiaojian Wang, et al.. (2007). CCL21 Is an effective surgical neoadjuvant for treatment of mammary tumors. Cancer Biology & Therapy. 6(8). 1217–1221. 11 indexed citations

Turnquist, Hēth, Xuede Lin, Abdelkader E. Ashour, et al.. (2007). CCL21 induces extensive intratumoral immune cell infiltration and specific anti-tumor cellular immunity. International Journal of Oncology. 30(3). 631–9. 42 indexed citations

Lin, Xuede, et al.. (1999). Reduction in hMSH2 mRNA Levels by Premature Translation Termination (Implications for Mutation Screening in Hereditary Nonpolyposis Colorectal Cancer). Digestive Diseases and Sciences. 44(3). 553–559. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact